5-HT³-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of Their Side-Effect Profile

5-HT3-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of THeir Side-Effect Profile Susan Goodin, Regina Cunningham Oncologist 2002; 7: 424-436 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: List the differences in side-effect profiles of the 5-HT3-receptor antagonists. Explain the potential issues of each 5-HT3-receptor antagonist in patients with cardiovascular disease. Understand the potential issues of each 5-HT3-receptor antagonist in patients with hepatic or renal impairment. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Oct. 25, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Oct. 25, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.